Gold Miners, Conflict, and a New Ebola Threat

Why Experts Are Worried About the Bundibugyo Strain, Even Though It Kills Fewer People Than the Zaire Ebolavirus and May Be Harder to Contain

Image Credit: ChatGPT 2.0

I remember the Sunday the pastor came to our church in Ibadan, Nigeria. He had traveled from Sierra Leone, where he ran a small congregation in Bombali district. Pastor Victor was Nigerian by birth, a missionary by calling, and visibly thinner than a man of his age should have been. He had survived Ebola. His assistant pastor had not.

It was 2014. I was finishing my clinical posting at a small cottage hospital near Eleyele, watching the outbreak unfold in news reports and ward conversations. The numbers coming out of West Africa were staggering: over 11,000 dead across Guinea, Liberia, and Sierra Leone by the time it was over. The Zaire strain. The one that killed nine out of every ten people it found in the worst-documented cases.

Pastor Victor stood at the pulpit and talked about watching members of his congregation go from fever to bleeding gums to silence in less than a week. He spoke about the burials that had to happen fast, before grief had time to settle. He spoke about the men who carried bodies without gloves because there were no gloves.

I kept thinking about the arithmetic. Ninety percent fatality. That number made everything else legible. You could understand the fear, the flight, the collapse of healthcare systems. High mortality drives people away faster than the virus, which is itself the problem, but at least you could map the logic of the panic.

What I did not know then was that there was another strain. Quieter. Less lethal on paper. And in some ways, harder to stop.

The number that misleads you

Here is what the current outbreak looks like on a spreadsheet: 600 infected. 139 dead. A fatality rate of between 30 and 50 percent.

In the language of epidemiology, that makes the Bundibugyo strain a moderate-severity pathogen. Dangerous, yes. But nowhere close to the 90 percent ceiling that Zaire could reach. If you plot both strains on a mortality graph, Bundibugyo looks almost manageable.

That graph is lying to you!

The death rate tells you how sick the virus makes people. It does not tell you how far the virus has already traveled while you were looking at the numbers. It does not tell you whether the tools sitting in your response kit will actually work on this particular strain. And it does not tell you anything about the terrain.

The Zaire outbreaks that researchers and governments mobilised to stop (2014 in West Africa, 2018 in eastern Congo ) spread through places where governments still controlled roads, where health workers could set up treatment units, where the public health infrastructure, however battered, still had a skeleton to hang response measures on.

Bundibugyo is spreading through Ituri Province. That changes every calculation.

What Ituri looks like from ground level

Ituri sits in the northeastern corner of the Democratic Republic of Congo, pressed against the Ugandan border. Nearly seven million people live there. Most of them are poor in the way that Westerners use the word “poor” to mean something abstract, when what they actually mean is: no clean water at the clinic, no ambulance to call, no road that does not wash out every rainy season.

But Ituri has gold.

Not gold in a bank vault somewhere. The kind you find by digging hand-cut pits in the jungle floor, by climbing down ropes into dark shafts that collapse without warning when the rains come early. Men from across the region go to those pits because hunger is heavier than fear. They go from the Congo to Uganda and to wherever the distance between where they are and where the gold is feels worth crossing.

Nobody in that part of Ituri uses official roads anymore. Gold moves through motorcycle couriers, cutting footpaths toward the border. So does ammunition. So do sick people.

This is the terrain where the Bundibugyo strain is moving.

Armed groups control whole stretches of territory: M23 fighters, local militia, men with guns, and rotating allegiances. They do not negotiate with health workers in white protective suits and chlorine tanks. They operate on a logic that the World Health Organization has no framework for. One week, an armed group allows a vaccination team through a checkpoint, the next week they do not, because the politics shifted overnight.

Twelve aid workers were killed in eastern Congo between 2018 and 2020 during the previous Ebola response. Not as collateral damage. Targeted. Because in a place where every outside actor is suspect, a man in a hazmat suit can look like an agent of the government, or worse, an agent of whoever the government owes favors to.

When Pastor Victor survived Ebola in Bombali, he was in a village church in Sierra Leone. The Sierra Leone government was functioning. International teams could land at Freetown airport and drive north. There were roads.

In Ituri, there are checkpoints. And guns. And fog.

The problem with the tools we built

After the 2014 West Africa outbreak, the world poured money into Ebola vaccines and therapeutics. The rVSV-ZEBOV vaccine, marketed as Ervebo, was licensed in 2019 after a trial in DRC showed it could stop Zaire transmission when deployed fast enough in ring vaccination campaigns. Researchers worked for years on monoclonal antibody treatments: mAb114, REGN-EB3. The data were strong. The tools worked.

Against Bundibugyo, the picture is different. The research base is thin. The two strains share enough genetic material that scientists have reason to hope for cross-protection, but reason to hope is not the same as evidence that it will hold. A vaccine trial cannot tell you what you need to know until a large enough outbreak creates the statistical population you need, which means waiting for enough people to get sick and die to run the numbers. Nobody wants to wait for that.

The uncertainty seeps into every layer of the response. How do you treat a patient when the therapeutics were designed for a different virus, and the dosing data you have comes from fewer cases than you need for confidence? How do you predict severity when your severity models were built on Zaire data? How do you tell a health worker in a camp outside Komanda: go into that room, the protective equipment works, the treatment works, you will be all right?

You cannot tell them that. Not with the data currently on hand.

This is what researchers mean when they say Bundibugyo keeps them awake. Not the death rate. The uncertainty.

How a virus moves when nobody is watching

In the mining corridor, people track two things with precision: the price of gold per gram in Kampala and the location of the nearest armed group.

Everything else is approximate. Including health.

When the first man in a camp falls sick, everyone assumes malaria. Because in Ituri, everything begins as malaria until it becomes something worse. The camp nurse gives him tablets and tells him to drink water. By the time the fever bends him double, three other men have sat beside him, handed him water, and touched the same plastic basin afterward.

Panic requires certainty, and in a war zone, certainty is a luxury.

The sickness spreads strangely. It enters a room before anyone notices it is there. One miner crosses into Uganda through a forest path, carrying gold dust and a fever that has not yet declared itself. He passes through three border communities before anyone thinks to check. A trader follows the same route two days later. A fighter resupplying a forward camp comes back with medicine and brings the virus along with the antibiotics.

By the time health workers arrive with contact-tracing lists and chlorine stations, the chain is five nodes long and crosses two countries.

The 2018 to 2020 Ebola outbreak in eastern Congo lasted nearly two years. It infected over 3,400 people and killed more than 2,200, making it the second-largest Ebola outbreak in history. Researchers and responders did everything right by the textbook: rapid vaccination, contact tracing, and community engagement. It still took twenty-three months to end because the virus was moving through the same corridor, the same roads, the same pit-mining communities, the same informal border crossings that now carry Bundibugyo.

They shut down that outbreak. Eventually. With the Zaire tools, the Zaire vaccines, the Zaire protocols. This time, the virus is different. The corridor is the same.

What the numbers still cannot tell you

In 2007, the Bundibugyo strain surfaced for the first time in Bundibugyo District in western Uganda. Researchers confirmed 116 cases and 39 deaths, a fatality rate of roughly 34 percent. Scientists had never seen this strain before. They sequenced the genome, classified it as a distinct species within the Ebolavirus genus, and noted that it was less lethal than Zaire but capable of sustained human-to-human transmission.

Then it went quiet.

Nobody built a vaccine for it or ran a large-scale therapeutic trial. There wasn’t a reason to: the outbreak was contained, the numbers were small, and the world’s attention was elsewhere. Now it is back. With 600 cases and the geography of a nightmare.

The point researchers keep returning to is not the case fatality rate (CFR). It is what epidemiologists call the basic reproduction number: how many new people one sick person infects before they either recover or die. A virus with a lower death rate can still spread faster if it produces milder symptoms early, which means people keep moving, keep working, keep crossing borders before they know they are sick. The Bundibugyo strain’s profile fits that pattern uncomfortably well: high enough mortality to kill, but not so dramatic as to immediately announce itself.

Image Credit: Chat GPT 2.0

A virus that kills nine out of ten people terrifies a community into stillness. A virus that looks like malaria for the first three days keeps the mining pits running, keeps the motorcycle couriers on the footpaths, keeps the border informal. That is the paradox nobody puts in the headlines.

What the pastor did not know, and what we still don’t

When Pastor Victor stood at that pulpit in Ibadan, he was describing something that had already ended. The worst was over. The tools worked. The world had mobilised. Thirty-odd nations, the largest international public health response in history, $3.6 billion spent.

And even then, over 11,000 people died.

Bundibugyo will not kill nine out of ten. But a 30 to 50 percent mortality rate, running through a war zone with seven million people, weak clinics, no roads, armed checkpoints, and a mining corridor connecting Congo to Uganda, does not need to reach Zaire numbers to become catastrophic.

The thing Kasereka said at the mining camp outside Komanda has stayed with me: “Nobody will ever know how this really started.”

He was talking about the war and the sickness, both, the way they braided together until you could not separate one from the other. You could not trace the first case because tracing requires record-keeping, and record-keeping requires a functioning civil system, and functioning civil systems do not thrive under gunfire.

In West Africa in 2014, we had the records. We had, eventually, the roads and the airports and the response infrastructure to match.

In Ituri, we have a different virus, the same impossible terrain, and a toolbox built for something else. That is why researchers are not calm.

They are watching a 30 to 50 percent fatality virus move through a place where the conditions for stopping it barely exist, armed with vaccines and treatments tested on its deadlier cousin, hoping the cross-protection holds, knowing that if it does not, the window for a different kind of response is already closing.

The gold pits are still open. The motorcycle couriers are still running. The border is still informal. And somewhere on the forest path between Ituri and Uganda, the virus is still moving.

A note on what this means for the rest of us

The last time a haemorrhagic fever that started in a remote African corridor reached beyond the continent, it took eleven thousand lives, a global emergency declaration, and a year and a half to stop.

That was with a virus the world had studied for forty years. Bundibugyo has been studied for eighteen.

This is not a prediction. It is arithmetic. A less-studied virus, spreading through harder terrain, with fewer verified tools, gets worse the longer it takes to solve. The WHO has already declared a public health emergency. Uganda has activated border surveillance. Researchers are scrambling to assess whether existing vaccines provide any meaningful cross-protection.

Scrambling takes time. In a mining corridor where everything moves fast, gold, fighters, sickness, and time are the one thing the response does not have enough of.

What I keep thinking about is the plastic basin.

After Alphonse died, everyone washed their hands in the same plastic basin. Not because they were careless. Because there was only one basin, and they had been sharing things all their lives, and the alternative, treating a dying man like something contaminated, was not something men who had known each other in the pits could bring themselves to do.

That detail is the whole story.

Not the death rate. Not the vaccine gap. The basin.

Public health breaks down at exactly the place where human solidarity takes over. Where the logic of survival makes people reach toward each other instead of away. Where a man hands another man water because you cannot leave a man alone like a dog.

Every outbreak in every war zone has a basin somewhere in it.

The question is never whether a virus is lethal enough to scare people into compliance. The question is whether the response arrives before the virus has already moved through every basin in the corridor.

Right now, in Ituri, that is still an open question.

Joshua Ogbonna is a writer and healthcare investment analyst based in Nigeria. He covers medicine, philosophy, policy, and the places where they collide.